Whitefort Capital Management, LP
Follow13F filer, CIK 1884931, NEW YORK, NY
Whitefort Capital Management, LP reported $208,958,079 across 18 holdings for the quarter ended 2024-12-31, in a 13F-HR filed 2025-02-14. Its ten largest share positions make up 92.87% of the portfolio.
Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001013594-25-000295
- Period
- 2024-12-31
- Reported value
- $209M
- Holdings
- 18
- Top 10 weight
- 92.87%
- New
- 1
- Sold out
- 1
Largest buys vs the previous quarter
| Security | Shares change | Approx. value |
|---|---|---|
| CDZInew | +3,719,951 | $19.3M |
| LQDAadded | +285,220 | $3.35M |
| ABUSadded | +373,949 | $1.22M |
| GSLadded | +2,997 | $65.4K |
Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.
Largest sells vs the previous quarter
| Security | Shares change | Approx. value |
|---|---|---|
| EDRreduced | -500,000 | -$15.6M |
| CORZexited | -1,147,500 | -$13.6M |
| NNreduced | -623,241 | -$9.7M |
| JOYYreduced | -145,451 | -$6.09M |
| NNAVWreduced | -382,071 | -$2.19M |
Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.
Holdings, Q4 2024
Share positions as resolved from 13F-HR 0001013594-25-000295, largest first. % of portfolio is the value over $208,958,077, the sum of the share positions whose value is usable for ratios (method).
| Security | History | Shares | Value | % of portfolio | Change | Latest event | Timeline |
|---|---|---|---|---|---|---|---|
| ABUSARBUTUS BIOPHARMA CORP | 13,241,916 | $43.3M | 20.72% | +373,949 | Timeline | ||
| ROIVROIVANT SCIENCES LTD | 2,391,000 | $28.3M | 13.54% | 0 | Timeline | ||
| LQDALIQUIDIA CORPORATION | 1,987,245 | $23.4M | 11.18% | +285,220 | Timeline | ||
| GNWGENWORTH FINL INC | 2,986,960 | $20.9M | 9.99% | 0 | Timeline | ||
| CDZICADIZ INC | 3,719,951 | $19.3M | 9.26% | new | Timeline | ||
| JOYYJOYY INC | 420,427 | $17.6M | 8.42% | -145,451 | Timeline | ||
| EDRENDEAVOR GROUP HLDGS INC | 500,000 | $15.6M | 7.49% | -500,000 | Timeline | ||
| NNNEXTNAV INC | 629,590 | $9.8M | 4.69% | -623,241 | Timeline | ||
| GSLGLOBAL SHIP LEASE INC | 369,768 | $8.07M | 3.86% | +2,997 | Timeline | ||
| MAIDEN HOLDINGS LTDMAIDEN HOLDINGS LTD | 1,997,005 | $3.37M | 1.62% | -51,158 | |||
| VATEINNOVATE CORP | 320,131 | $1.58M | 0.76% | 0 | Timeline | ||
| NNAVWNEXTNAV INC | 100,880 | $579K | 0.28% | -382,071 | Timeline | ||
| OPKOPKO HEALTH INC | 134,490 | $198K | 0.09% | 0 | Timeline | ||
| TRIBTRINITY BIOTECH INVT LTD | 81,902 | $72.1K | 0.03% | 0 | Timeline | ||
| ALTENERGY ACQUISITION CORPALTENERGY ACQUISITION CORP | 186,315 | $783 | <0.01% | 0 |
Principal amounts
Notes and convertibles filed as a face amount (PRN). A face amount is never added to a share count (H6).
| Security | Type | Amount | Value | Change |
|---|---|---|---|---|
| Esperion Therapeutics IncEsperion Therapeutics Inc NOTE 4.000%11/15/25 | principal | 8,000,000 | $7.77M | 0 |
| SABRE GLBL INCSABRE GLBL INC BOND | principal | 5,000,000 | $4.94M | 0 |
| INNOVATE CORPINNOVATE CORP NOTE 7.500% 8/0 | principal | 12,218,000 | $4.16M | 0 |
Sold out in Q4 2024
Positions in the previous quarter's report that this quarter's report no longer lists.
| Security | Shares before | Value before | Type |
|---|---|---|---|
| CORZCORE SCIENTIFIC INC NEW | 1,147,500 | $13.6M | shares |
How Q4 2024 was built
Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).
| Filing | Role | Amendment | Filed | Accepted | Ingested |
|---|---|---|---|---|---|
| 13F-HR 0001013594-25-000295 | base | 2025-02-14 | acceptance time not in the bulk data set |